Previous Page  266 / 320 Next Page
Information
Show Menu
Previous Page 266 / 320 Next Page
Page Background

670

47. Faulkner, C. M., Cox, H. L., & Williamson, J. C. (2005).

Unique aspects of antimicrobial use in older adults. Clinical

Infectious Diseases : an Official Publication of the Infectious

Diseases Society of America, 40(7), 997–1004. http://doi.

org/10.1086/428125.

48. Sujino MD, Y. (2014). Impact of hypoalbuminemia, frailty,

and body mass index on early prognosis in older patients (

85

years) with ST-elevation myocardial infarction. Journal of

Cardiology, 1–6.

http://doi.org/10.1016/j.jjcc.2014.12.001.

49. Jason A. Roberts, (2012). The Clinical Relevance of Plasma

Protein Binding Changes. Clinical Pharmacokinetics, 52(1),

1–8.

http://doi.org/10.1007/s40262-012-0018-5.

50. Butler, J. M., & Begg, E. J. (2008). Free drug metabolic clearance

in elderly people. Clinical Pharmacokinetics, 47(5), 297–321.

http://doi.org/10.2165/00003088-200847050-00002.

51. Gurevich, K. G. (2013). Effect of blood protein concentrations

on drug-dosing regimes: practical guidance. Theoretical

Biology & Medical Modelling, 10(1), 20. http://doi.

org/10.1186/1742-4682-10-20.

52. Pasina, L., Brucato, A. L., Falcone, C., Cucchi, E., Bresciani,

A., Sottocorno, M., et al. (2014). Medication non-adherence

among elderly patients newly discharged and receiving

polypharmacy. Drugs & Aging, 31(4), 283–289. http://doi.

org/10.1007/s40266-014-0163-7.

53. Hajjar, E. R. (2014). Clinical consequences of polypharmacy in

elderly. Expert Opinion on Drug Safety, 13(1), 57–65. http://

doi.org/10.1517/14740338.2013.827660.

54. Marcum, Z. A., & Gellad, W. F. (2012). Medication adherence

to multidrug regimens. Clinics in Geriatric Medicine, 28(2),

287–300.

http://doi.org/10.1016/j.cger.2012.01.008.

[REV. MED. CLIN. CONDES - 2016; 27(5) 660-670]